Inovio Pharma (INO)
$23.68
0.22 (0.94%)
INO Stock Quote Delayed 30 Minutes
Previous Close
$23.46
Market Cap
2.15B
PE Ratio
-20.77
EPS
-1.14
Volume (Avg. Vol.)
19.82M
Day's Range
22.91 - 24.52
52-Week Range
1.92 - 33.79
Dividend & Yield
N/A (N/A)
INO Stock Predictions, Articles, and Inovio Pharma News
Without First Mover Advantage, Things Don’t Look Great for Inovio Stock
Given Inovio's challenges and the very high valuation of INO stock, I recommend selling the shares.
Inovio’s Dramatic 30% Drop Will Be Short-Lived
Fundamentally, the positive clinical data suggests that INO stock is on the right path to generating strong revenues as early as next year.
Inovio Pharmaceuticals Comes Up Short in Phase 1
The competition for a Covid-19 vaccine is intense. Inovio needs to provide investors with more information to give INO stock a chance at long-term upside.
5 Top Stock Trades for Wednesday: GLD, MU, GOLD, INO, UBER
Micron, the gold ETF, Barrick Gold, Inovio and Uber were our top stock trades for Wednesday. That said, let's look at the charts now.
Be Careful with Novavax and the Recent Surge in NVAX Stock
Covid-19 vaccine stocks are on fire, but many of them appear to be out over their skis, including the group's hottest name, NVAX stock.
Tread Carefully With INO Stock, Because Inovio Is Far From a Sure Thing
Covid-19 vaccine stocks are red-hot right now thanks to the emergence of a second wave, but I'd be careful chasing this rally in INO stock.
4 Top Stock Trades for Friday: SQ, INO, MKC, SRNE
McCormick, Sorrento, Square and Inovio were our top stock trades from Thursday. So, let's look at the charts to see what's going on now.
Inovio Pharmaceuticals Stock on Fire After DOD Signs COVID-19 Contract
Inovio stock has already been a strong performer in 2020, but news of a DOD contract for COVID-19 vaccine applicators has INO stock soaring.
Inovio Pharmaceuticals News: INO Stock Shoots 44% Higher on DoD Contract
Inovio Pharmaceuticals (INO) is in the news Tuesday after a contract with the U.S. Department of Defense sent INO stock soaring higher.
Inovio Pharma’s Next Clinical Results Will be Binary for INO Stock
Inovio Pharma's next clinical results will be a binary event for INO Stock. It will rise or fall based on its Phase 1 results due out by the end of June.
Stay Safe on the Sidelines With Inovio Stock
With its coronavirus vaccine candidate facing slim chances of success, it's probably best to stay on the sidelines with INO stock.
It’s Time to Take Your Profits From Choppy Inovio Stock
INO stock has been on a tear in recent months, but the shares may not necessarily make any new highs. Consider taking your profits now.
The Case for Buying Inovio Will Come Down to the Test Results
INO stock is up over 300% in 2020. But investors are going all in on the company's Covid-19 vaccine candidate, and that's still a gamble.
Inovio Stock Is Still a Strong Coronavirus-Related Bet to Make
Inovio is speeding toward a vaccine for the coronavirus and has plans to make 1 million doses by the end of the year to boost INO stock.
Inovio Stock Still Has Strong Technicals – Here’s the Trade
Inovio has an attractive technical profile, but not very good fundamentals. Let's look at what bulls can utilize in INO stock.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
